Bicycle Therapeutics (BCYC) Stock Chart & Stock Price History $14.53 -0.15 (-1.02%) (As of 12:33 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Bicycle Therapeutics Stock Price Performance 5 Day Performance-6.21%1 Month Performance-30.09%3 Month Performance-40.09%6 Month Performance-30.05%Year-To-Date Performance-20.58%1 Year Performance-23.09% Receive BCYC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bicycle Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Is Starlink Set For The Largest IPO In History? (Ad)He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!Click here now for the urgent details. BCYC Stock Chart for Monday, December, 23, 2024 BCYC Chart by TradingView Bicycle Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024$15.00$14.68-2.13%$15.30$14.64346,432 shs$1.01 billion12/19/2024$15.31$15.00-2.02%$15.39$14.75475,140 shs$1.04 billion12/18/2024$15.14$15.31+1.12%$17.03$14.79657,158 shs$1.06 billion12/17/2024$15.12$15.14+0.13%$15.85$14.952.23 million shs$1.05 billion12/16/2024$13.81$15.12+9.49%$15.72$13.881.96 million shs$1.04 billion12/13/2024$20.11$13.81-31.33%$17.78$12.175.71 million shs$953.58 million Get the Latest News and Ratings for BCYC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bicycle Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024$21.09$20.11-4.65%$21.11$20.11307,887 shs$1.39 billion12/11/2024$20.86$21.09+1.10%$21.21$20.60260,545 shs$1.46 billion12/10/2024$21.05$20.86-0.90%$21.50$20.14734,345 shs$1.44 billion12/09/2024$19.95$21.05+5.51%$21.29$19.84755,772 shs$1.45 billion12/06/2024$19.21$19.95+3.85%$20.24$19.25139,585 shs$948.62 million12/05/2024$19.68$19.21-2.39%$19.85$18.80663,709 shs$913.44 million12/04/2024$19.45$19.68+1.18%$19.83$19.30170,112 shs$935.78 million12/03/2024$20.01$19.45-2.80%$20.51$19.29455,982 shs$924.85 million12/02/2024$20.40$20.01-1.91%$21.00$19.92156,585 shs$951.48 million11/29/2024$20.35$20.40+0.25%$20.72$20.20208,916 shs$970.02 million11/28/2024$20.35$20.35$20.53$20.16238,848 shs$967.64 million11/27/2024$20.40$20.35-0.25%$20.53$20.16196,748 shs$967.64 million11/26/2024$19.95$20.40+2.26%$21.33$19.90308,879 shs$970.02 million11/25/2024$20.54$19.95-2.87%$21.45$19.94228,642 shs$948.62 million11/22/2024$20.35$20.54+0.96%$21.33$20.27536,420 shs$976.76 million Related Companies Apellis Pharmaceuticals Stock Chart Scholar Rock Stock Chart Biohaven Stock Chart Avidity Biosciences Stock Chart Immunovant Stock Chart Organon & Co. Stock Chart PTC Therapeutics Stock Chart Verona Pharma Stock Chart Rhythm Pharmaceuticals Stock Chart MoonLake Immunotherapeutics Stock Chart Receive BCYC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bicycle Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BCYC) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bicycle Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Bicycle Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.